Healthcare -
Biotechnology - NASDAQ - US
$ 20.59
0.869 %
$ 15.2 B
Market Cap
-58.03
P/E
SMMT - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities SMMT - Summit Therapeutics Inc.
381 M
LAST VALUE
-21.60%
2 YEAR CAGR
59.04%
5 YEAR CAGR
28.54%
10 YEAR CAGR